
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before April 2027)
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.


